Skip to main content

Information updates

ASCIA 2022 Conference Health and Safety Measures - July 2022

The ASCIA 2022 Conference is being held as a hybrid event, which enables in-person or virtual attendance.  

ASCIA and the Melbourne Convention and Exhibition Centre (MCEC) will have measures in place for in-person attendance, to ensure that the ASCIA 2022 Conference will be held in the safest possible way, to protect the health of everyone involved.

These measures include:

  • Physical distanced seating arrangements (round tables) and limited delegate numbers in each room
  • Eco box catering instead of lunch buffets
  • Sanitisation stations throughout the venue
  • Mask wearing in the conference and rapid antigen testing prior to attending is recommended

To further minimise risk, the Welcome Function will not proceed this year, as this type of large cocktail style function is deemed to be a high risk for spreading infections. Instead we will ensure that all other catering is of the highest quality, with a range of premium lunch and break menus.

Dinners will still proceed on the Wednesday evening (Trainee and Consultants Dinner) and Thursday evening (Gala Dinner) and these events will include health and safety measures.  

ASCIA recommends:

  • Travel insurance for all delegates who are travelling to attend in-person.
  • Virtual registration for people who are unwell or hesitant to attend in-person due to serious health concerns.

DO NOT ATTEND THE ASCIA 2022 CONFERENCE IF YOU HAVE ANY COVID-19, INFLUENZA OR COLD SYMPTOMS. 

If anyone experiences COVID-19, influenza or cold symptoms whilst attending the ASCIA 2022 Conference in-person, they should leave the venue immediately, isolate and test. If this isn't possible, venue staff can escort the person to an isolation room and provide a rapid antigen test for immediate assessment.

For all other first aid incidents first aid rooms are located on the Ground Floor of the MCEC. 

The MCEC venuesafe plan is available at https://mcec.com.au/venuesafe/visitor 

 

This news item was issued on 27 July 2022 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.